Lisanti Capital Growth, LLC
Position in KNSA — Kiniksa Pharmaceuticals International, plc
CIK 1424467
NEW YORK, NY
Position in KNSA
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$5,583,154
+$4,087,375 QoQ
Shares Held
87,305
+181.0% QoQ
Ownership
0.056%
of shares outstanding
% of Portfolio
1.25%
of 13F equity value
Holder Rank
#62
of 266 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KNSA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Lisanti Capital Growth, LLC holds $5,583,154 across 1 Drug Manufacturers - Specialty & Generic name. KNSA ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KNSA |
Kiniksa Pharmaceuticals International, plc
This page
|
87,305 | $5,583,154 |
All Filings in KNSA
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,583,154 | 87,305 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $1,495,779 | 31,065 | Shares | Sole | 2026-05-07 | |
| No filing history on record for this holder in this stock. | ||||||